Schonfeld Strategic Advisors LLC

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1665241 NEW YORK, NY

Position in AGIO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$6,768,063

+$5,226,596 QoQ

Shares Held

200,061

+331.7% QoQ

Ownership

0.336%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Schonfeld Strategic Advisors LLC holds $295,904,773 across 126 Biotechnology names. AGIO ranks #13 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	FOLD	AMICUS THERAPEUTICS, INC.	1,757,899	$25,419,219
2	ALNY	Alnylam Pharmaceuticals, Inc.	71,767	$23,745,547
3	PTCT	Ptc Therapeutics, Inc.	318,405	$21,692,932
4	XENE	Xenon Pharmaceuticals Inc.	324,722	$18,882,584
5	INBX	Inhibrx Biosciences, Inc.	254,827	$17,132,019
6	JAZZ	Jazz Pharmaceuticals plc	62,142	$11,747,945
7	RARE	Ultragenyx Pharmaceutical Inc.	494,737	$10,364,740
8	INSM	INSMED Inc	56,056	$9,166,277

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,768,063	200,061	+331.7%	Shares	Sole	2026-05-15
2025-06-30	$1,541,467	46,346	+96.4%	Shares	Sole	2025-08-14
2025-03-31	$691,480	23,600	-24.2%	Shares	Sole	2025-05-15
2024-12-31	$1,023,654	31,152	+0.4%	Shares	Sole	2025-02-14
2024-09-30	$1,378,307	31,022	-93.3%	Shares	Sole	2024-11-14
2024-06-30	$20,012,897	464,121	+1858.3%	Shares	Sole	2024-08-14
2022-12-31	$665,496	23,700	+109.7%	Shares	Sole	2023-02-14
2021-12-31	$371,431	11,300	-48.7%	Shares	Sole	2022-02-14
2021-06-30	$1,214,348	22,035	-20.6%	Shares	Sole	2021-11-16
2021-03-31	$1,432,287	27,736	+23.7%	Shares	Sole	2021-05-17
2020-09-30	$784,980	22,428	+254.1%	Shares	Sole	2020-11-19
2020-06-30	$338,742	6,334	-2.1%	Shares	Sole	2020-09-15
2020-03-31	$229,484	6,468	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.